View Post

Debunking 4 myths about cancer clinical trials: The unsung hero of breast cancer research

In In The News by Barbara Jacoby

By: Anil Sethi From: medcitynews.com Clinical trials are the safest and most trusted route for identifying new breast cancer treatments, and the more research that can be done, the closer we will be to eradicating breast cancer for good. Clinical trials are the most effective tool to finding groundbreaking medical treatments. The first large-scale breast cancer prevention study in 1998, …

View Post

Outcomes4Me Incorporates NCCN Guidelines® Update into Mobile App for Breast Cancer Patients

In In The News by Barbara Jacoby

Source: Outcomes4Me From: prnewswire.com Update includes new treatments, pembrolizumab and olaparib, for early-stage breast cancer Outcomes4Me Inc. today announced it has updated its mobile app to include the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.6.2021 released last week. The app serves as a digital health partner that proactively delivers timely information of value to empower patients …

View Post

Most Women With Metastatic Breast Cancer Have Troubling Treatment Side Effects, Willing To Discuss Dosing Options With Doctor

In In The News by Barbara Jacoby

By: Jamie DePolo From: breastcancer.org About 86% of women diagnosed with metastatic breast cancer had at least one bad treatment-related side effect, and 92% were willing to discuss options for different dosing levels of medicines based on their unique situations, according to a study. The research was presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. About …

View Post

Innovations in the Treatment of HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Sara Karlovitch From: targetedonc.com In an interview with Targeted Oncology, Komal Jhaveri, MD, FACP, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses HER2-positive metastatic breast cancer innovations, treatments, and upcoming studies. Major advances have been made in the HER2-positive breast cancer space in both the first-line and later-line settings. First, in 2015, the results from the CLEOPATRA …

View Post

How to Navigate Metastatic Breast Cancer Test Results

In In The News by Barbara Jacoby

From: healthline.com Metastatic breast cancer (MBC), also called stage 4 or advanced breast cancer, means that breast cancer has spread beyond the breast and nearby lymph nodes to other organs in the body, like the bones or brain. Not all breast cancers are the same. If you’ve already received an MBC diagnosis, your doctor will most likely perform additional tests …

View Post

Escalation and De-escalation of Therapy Beneficial in HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Debu Tripathy, MD From: targetedonc.com Debu Tripathy, MD, discusses escalation and de-escalation of treatment in patients with HER2-positive breast cancer with HER2-targeted agents and chemotherapy. Debu Tripathy, MD, professor of medicine and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses escalation and de-escalation of treatment in patients with HER2-positive …

View Post

HER2-Positive Breast Cancer Survival Rates and Other Statistics

In In The News by Barbara Jacoby

From: healthline.com Breast cancer isn’t a single disease. It’s actually a group of diseases. When diagnosing breast cancer, one of the first steps doctors take is identifying the type of breast cancer. The type provides key information about how the cancer may behave. About 13 percent of women in the United States will develop invasive breast cancer. Anyone can develop …

View Post

Breast Cancer Armamentarium Offers New Options for Patients

In In The News by Barbara Jacoby

By: Sagar Shah, PharmD candidate; and Saro Arakelians, PharmD From: pharmacytimes.com Breast cancer is the second-leading cause of cancer-related death among women in the United States.1 Each year, about 250,000 cases of breast cancer are diagnosed in the United States.2 According to the American Cancer Society, about 276,480 cases of breast cancer will be diagnosed in women in 2020. About …

View Post

Ask the Expert: 8 Things to Consider About Treatment for MBC

In In The News by Barbara Jacoby

From: healthline.com 1. What treatments are available for postmenopasal women with MBC The metastatic breast cancer (MBC) treatment plan your doctor will recommend depends on whether the tumors have receptors for estrogen or progesterone or elevated levels of human epidermal growth factor receptor 2 (HER2). These are known as a tumor’s biologic subtype. There are various targeted therapies for each …

View Post

Optimal Sequencing Remains a Hurdle in Ovarian Cancer Treatment

In Clinical Studies News by Barbara Jacoby

By: Brittany Lovely From: onclive.com The surge of treatment options for patients with ovarian cancer poses a daunting challenge as answers for optimal sequencing continue to elude clinicians. Bevacizumab (Avastin) continues to hold the most utility in this disease setting, but the addition of PARP inhibitors, and immunotherapy raises the question of how to best deliver efficient regimens to patients. …